Select Medical Hldgs Q2 2024 Adj. EPS $0.60 Misses $0.61 Estimate, Sales $1.760B Beat $1.745B Estimate
Portfolio Pulse from Benzinga Newsdesk
Select Medical Holdings (NYSE:SEM) reported Q2 2024 earnings per share (EPS) of $0.60, missing the analyst consensus estimate of $0.61 by 1.64%. However, the company reported sales of $1.760 billion, beating the estimate of $1.745 billion by 0.88%.
August 01, 2024 | 9:16 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Select Medical Holdings reported Q2 2024 EPS of $0.60, missing the consensus estimate of $0.61. However, sales of $1.760 billion beat the estimate of $1.745 billion. The mixed results may lead to short-term volatility in the stock price.
The mixed earnings report, with EPS missing but sales beating estimates, suggests potential short-term volatility. Investors may react negatively to the EPS miss but positively to the sales beat, resulting in a neutral overall impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100